A biotechnology fund that came under market scrutiny after offering investors juicy returns has lent millions of dollars to companies run by its boss.
The bond facility arrangements between Ethical Bioscience Investment Fund and the other iQ Group Global companies are the latest in related party deals involving the Sydney-based life sciences outfit.
Loading...
Liam Walsh writes on investigations and companies with The Australian Financial Review. He has won multiple media awards, worked in Japan and is now based in Brisbane. Email Liam at liam.walsh@afr.com.au
Jonathan Shapiro writes about banking and finance, specialising in hedge funds, corporate debt, private equity and investment banking. He is based in Sydney. Connect with Jonathan on Twitter. Email Jonathan at jonathan.shapiro@afr.com
